Becker's Healthcare July 9, 2020
Katie Adams

The National Institute of Allergy and Infectious Diseases, a division of the National Institutes of Health, on July 8 launched its COVID-19 Prevention Trials Network, a clinical trials network seeking to enroll thousands of participants in COVID-19 vaccine and antibody treatment testing.

Here are five things to know about the network:

  • Four NIAID-funded clinical trials networks joined forces to form the The COVPN: the Seattle-based HIV Vaccine Trials Network, the Durham, N.C.-based HIV Prevention Trials Network, the Atlanta-based Infectious Diseases Clinical Research Consortium and the Los Angeles-based AIDS Clinical Trials Group. The HIV Vaccine Trials Network...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Healthcare System, Pharma, Pharma / Biotech, Public Health / COVID
Will Synthetic, AI-Based Digital Humans Change Pharma and Life Sciences? Q&A with Abid Rahman, SVP Innovation, EVERSANA
Cerevel Parkinson’s data adds lustre to AbbVie acquisition
Pharma Pulse 4/19/24: The Health and Healthcare of Gen-Z, Long-Acting Drugs May Revolutionize HIV Prevention/Treatment & more
Recursion, Canaan, Metsera and more—Chutes & Ladders
Unlocking Targeted Cancer Care: Biomarkers as the Key to Personalized Treatments

Share This Article